Quantcast

Latest high-throughput screening Stories

2010-07-19 11:00:00

PARIS, July 19 /PRNewswire-FirstCall/ -- Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis (Alternext: ALCLS), today announced the publication of a scientific study describing a novel method, based on meganuclease-driven targeted integration, for the generation of stable cell lines compatible with high throughput screening (HTS)(1). The study demonstrated Cellectis bioresearch's technology to be faster, more reliable and efficient in deriving...

2010-06-29 06:00:00

SEATTLE, June 29 /PRNewswire-FirstCall/ -- Omeros Corporation (Nasdaq: OMER) today announced that it has successfully identified compounds that interact with three orphan G protein-coupled receptors (GPCRs) linked to cancer, metabolic disorders and appetite control. This breakthrough demonstrates Omeros' unique capability to introduce a large number of new drug targets to the pharmaceutical industry, which could lead to the development of novel therapeutics across a wide range of diseases...

2010-04-06 12:32:00

SUNNYVALE, Calif., April 6 /PRNewswire/ -- Today, Molecular Devices, Inc. announced that it will launch two new products--the IonWorks Barracuda System & the 96 Cell-Wash Head for the AquaMax 2000/4000 Microplate Washer--as well as its new Molecular Devices brand at the Society for Biomolecular Sciences (SBS) Annual Meeting in Phoenix, Arizona, April 13-16. The new Molecular Devices brand is focused on a serious commitment to meet customer needs and exceed customer expectations, and...

2010-03-24 15:35:54

The identification of compounds that could be promising candidates for drug development has become easier following research by the Walter and Eliza Hall Institute's medicinal chemistry group. Dr Jonathan Baell and Dr Georgina Holloway have developed a series of 'filters' that can be used to weed out those molecules likely to come up as false positives when screening a chemical library for compounds that could be useful in drug development. High-throughput chemical screening (HTCS) seeks to...

2010-02-01 08:00:00

GOTHENBURG, Sweden, February 1 /PRNewswire/ -- Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System....

2010-01-11 09:18:00

BANGALORE, India, January 11 /PRNewswire-FirstCall/ -- Jubilant Biosys Limited, based in Bangalore, an integrated Drug Discovery and Development solution provider, a subsidiary of Jubilant Organosys Ltd, headquartered in Noida, announced today that it has entered into a co-marketing agreement to provide screening solutions, with DiscoveRx Corporation (Fermont, USA), a premier provider of innovative cell based assay solutions for GPCR, Kinases, NHR and Proteases. This agreement allows...

2009-12-06 23:17:00

SHANGHAI, Dec. 7 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today it has purchased a Labcyte POD(TM) 810 plate assembler equipped with an Echo(R) 555 acoustic liquid handler for its work in high- throughput screening and secondary screening. WuXi PharmaTech joins the growing number of pharmaceutical companies worldwide...

2009-11-23 11:01:00

CAMBRIDGE, Mass., Nov. 23 /PRNewswire/ -- Ligon Discovery, Inc., which uses proprietary small molecule microarray technology to find drugs against high-value targets, today announced the appointment of pharmaceutical industry veteran Errol B. De Souza as Ligon's Executive Chairman of the Board. "I'm very pleased to welcome Errol De Souza as Executive Chairman of the Board," said Patrick Kleyn, Ligon's chief executive officer and co-founder. He added, "Errol's breadth of experience in the...

2009-10-28 10:12:00

NIAID contracts additional $700,000 to screen 300,000 more compounds for HIV inhibition CARY, N.C. and BIRMINGHAM, Ala., Oct. 28 /PRNewswire-USNewswire/ -- Trana Discovery, Inc., an infectious disease drug discovery technology company, and Southern Research Institute, a not-for-profit contract research organization conducting basic and applied preclinical drug research, today announced that several bioactive hits from a set of 15,000 diverse small molecule compounds screened under contract...

2009-09-18 07:52:42

Cancer and cell biology experts at the University of Cincinnati (UC) have developed a new mass spectrometry-based tool they say provides more precise, cost-effective data collection for drug discovery efforts. Preliminary studies have shown that the new mass spectrometry tool"”known as MALDI-QqQMS (matrix-assisted laser desorption ionization-triple quadruple mass spectrometer)"”provides a superior means of measuring the enzyme reactions critical to drug discovery at speeds...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.